NRG receives funding for nuclear medicine R&D centre

The Advancing Nuclear Medicine consortium, led by the Nuclear Research and Consultancy Group (NRG), has been awarded a EUR6.8 million (USD7.7 million) subsidy to develop FIELD-LAB. This Dutch initiative is aimed at accelerating the development and introduction of new radiopharmaceuticals.

The contribution by the Kansen voor West (which translates as Opportunities for the West) organisation is from the European Fund for Regional Development (EFRO). NRG - operator of the EU's High Flux Reactor at Petten in the Netherlands - said the contribution would "help to intensify and accelerate FIELD-LAB development and implementation".

To read more please visit: http://world-nuclear-news.org/Articles/NRG-receives-funding-for-nuclear-medicine-R-D-cent

Source: World Nuclear News